Monoclonal Antibody to Transmembrane Protein 27 (TMEM27)
| Code | Size | Price |
|---|
| MAK477Mu21-20ul | 20ul | £93.00 |
Quantity:
| MAK477Mu21-100ul | 100ul | £177.00 |
Quantity:
| MAK477Mu21-200ul | 200ul | £239.00 |
Quantity:
| MAK477Mu21-1ml | 1ml | £553.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Mouse
Antibody Clonality: Monoclonal
Regulatory Status: RUO
Target Species: Mouse
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Flow Cytometry
- Immunocytochemistry (ICC)
- Immunofluorescence (IF)
- Immunohistochemistry- Frozen Section (IHC-F)
- Immunohistochemistry- Paraffin Embedded (IHC-P)
- Immunoprecipitation (IP)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
NX17; Collectrin
Buffer Formulation:
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Item Name:
Transmembrane Protein 27
Potency (Clone Number):
C7
Reactivity:
Ra;
Source:
Monoclonal antibody preparation
Usage:
Western blotting: 0.01-5ug/mL;<br/>Immunocytochemistry in formalin fixed cells: 5-30ug/mL;<br/>Immunohistochemistry in formalin fixed frozen section: 5-30ug/mL;<br/>Immunohistochemistry in paraffin section: 5-30ug/mL;<br/>Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Transmembrane Protein 27 (TMEM27) | RPK477Mu01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||